A Multilayered Approach to Reliable Supply Service Levels

To meet the needs of health systems, McKesson is focusing on key areas to maintain ideal service levels and deliver reliable pharmaceutical distribution.

McKesson partners with health systems to deliver reliable pharmaceutical distribution.

Unstable inventory levels across the healthcare supply chain throughout the pandemic put a strain on hospitals and health systems, including limited access to personal protective equipment (PPE) for healthcare workers. Additionally, COVID-19 further exasperated drug shortage concerns due to unprecedented demand from large numbers of critically ill patients.

Amidst challenges like these, health systems need a reliable pharmaceutical distribution partner that can deliver. Here’s how we focus on maintaining ideal service levels to help health systems have the medicines they need when they need them to care for and focus on their patients.

A Multilayered Approach

To meet the needs of the health systems, we focus on three key areas: strategic investments, market forces, as well as data analysis and ongoing conversations.

Strategic Investments

We’ve made significant investments to operations in our distribution centers to make sure we have a strong workforce in place to move inventory through our supply chain quickly and efficiently.

In addition, we’ve made significant investments in increasing inventory levels in our forward distribution centers to secure supply to improve fill rates and minimize disruptions.

Market Forces

We pay special attention to what is happening in the global supply chain, from both the supply and demand sides. Through supplier communication, market insights or other analyses such as predictive analytics tools, we work to adjust as we identify potential supply shortages or other types of disruption.

Data Analysis and Ongoing Conversations

In providing insights to health systems, we understand they need both the quantitative with the qualitative. We engage by listening, particularly through our Critical Care Drug Task Force (CCDTF). The team of experts, assembled at the start of the pandemic, compares the number of COVID-19 cases reported on a local and national level with customer demand patterns and coordinates the forecasted supply needs with pharmaceutical manufacturers. The CCDTF provides health systems with a mix of data and dialogue.

Through our process of monitoring, coupled with strong communication and actionable plans, we are able help health systems by instilling confidence in our supply service levels. Learn more about how we partner with health systems.

top